Navigation Links
Experts Identify Vaccine Target for HIV

An international team of researchers has identified three gene variants in the DNA of 486 people infected with HIV that appear to have helped some of the patients fight off the virus and delay the onset of full-blown AIDS.

The researchers expect the new findings to aid the search for an HIV vaccine that would work by boosting the protective effects of one or more of these genes, and help the bodys own immune system overcome an infection. One of the genes looks particularly attractive as a vaccine target.

These findings represent only the first of what investigators said will be a series of future genome-wide studies to pinpoint additional targets for HIV vaccines. In the new analysis, patients with specific gene variants in key immune system cells appear to be much better at controlling the proliferation of the virus after infection. These gene variants are known as polymorphisms.

These results not only approximately double our understanding of the factors that influence variation amongst individuals in how they control HIV-1, but also point towards new mechanisms of control, said David Goldstein, Ph.D., director of the Center for Population Genomics and Pharmacogenetics at Dukes Institute for Genome Sciences and Policy and the senior author of the paper.

As we expand the number of patients in future studies conducted by CHAVI researchers, we aim to discover even more polymorphisms that could provide additional clues how some patients are better able to control the virus than others. This should ultimately lead to novel targets for vaccines, the primary goal of CHAVI., Goldstein.said.

Two of the polymorphisms found were in genes controlling the human leukocyte antigen (HLA) system, which plays a major role in the immune system by identifying foreign invaders and tagging them for destruction.

Two of the HLA genes, known as HLA-A and B, are turned off by HIV when it enters the body,
'"/>




Page: 1 2 3

Related medicine news :

1. Good carb, bad carb? Experts debate.
2. Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts
3. Experts Recommend Preventive Measures For Avian Flu To Begin From Farms
4. Experts Insist That Neonatal Herpes Be Reported Regularly
5. Experts State Strategies To Increase Good Cholesterol
6. Cancer Can Recur Any Time, Experts Caution
7. Experts Building Bird Flu Warning System
8. Human Growth Hormone (HGH) - View of Experts
9. Experts urging artery screening in the UK
10. Genetic Experts of Hopkins Assists In Identifying Hurricane Katrina Victims
11. Birds Being Shot Owing To Bird Flu Fear: Wildlife Experts
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Experts Identify Vaccine Target for HIV

(Date:5/17/2008)... gather to tell motorists ,Click It or Ticket ...schoolers display art and videos promoting seat be...hat: Local kickoff of the 2008 "Click It or Tick... Monday, May 19, 2008 Noon (free buffet... Where: The Cleveland House of Blues 308...
(Date:5/16/2008)...swire/ -- In the aftermath of central China,s,eart...st their lives, and,over 150,000 were injured. An ...th 4 million who have lost their homes. With great... Supreme Master Ching Hai donated an,additional US...ons from,Supreme Master Ching Hai International As...
(Date:5/16/2008)NEW YORK, May 16 /PRNewswire/ -- There,s more to a healthy mouth than,flashing a set of pearly whites. Here,s the scoop on America,s oral care,habits - and what it means for our overall health.,
(Date:5/16/2008)...PRNewswire-USNewswire/ -- This release is,being se...junction with the,National Cancer Institute, part ...d at the American Society of Clinical,Oncology mee...ment practice,in about 25 percent of patients with...s to the way colorectal cancers will be staged., ...
Breaking Medicine News(10 mins):Health News:Northeast Ohio Kicks Off the 2008 Click It or Ticket Campaign 2Health News:Northeast Ohio Kicks Off the 2008 Click It or Ticket Campaign 3Health News:Supreme Master Ching Hai International Association Delivering US$160,000 in Aid to Earthquake Survivors in China 2Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2
...were to be serious accidents or injury due to some...in the treatment of such persons in the emergency ...are undertaken in the intensive care are varied an...death of the patient. Scientists are now working ...
...rapy, which is touted as the best and latest in ca...y's Mater Hospital Radiotherpahy Department.// It..., and is set to improve results with fewer side ef...of its kind in the southern hemisphere, bringing t...
...ersy sparked off by a Holyrood committee’s call fo... of patients with hepatitis C through NHS treatmen...new evidence showing lack of resources was the rea...tients infected with the fatal virus, the Health C...
...people in Ratlam in Madhya Pradesh fell ill after ...ident in five days in the district, police said Th... to Ratlam district hospital, the rest were discha...spital spokesman said. Earlier, 35 people had fal...
Other Medicine News:Health News:Guidelines For Treating Severely Injured Patients On The Anvil 2
(Date:5/16/2008)...nual Meeting Will Further Demonstrate, the Stren... Myeloma -, CAMBRIDGE, Mass., May 16 /PRNewswire/...y Company, today announced that new data from VELC...at the 2008 American Society,of Clinical Oncology ... -,June 3, 2008. The data will highlight the signi...
(Date:5/16/2008)...and customer thought leaders -, SAN FRANCISCO, Ma...eader and trusted resource for clinical trial mana... prestigious academic medical centers, research,in...r group meeting in San,Francisco. The Velos eResea...aboratively manage thousands of clinical trials., ...
(Date:5/16/2008)...demonstrating that TYKERB and trastuzumab together...progression-free survival (PFS), -- Combining TYK...outside of the HER2 receptor may create a more com...ty of TYKERB alone despite patients,previous trea...therapy, LONDON and PHILADELPHIA, May 16 /PRNewsw...
(Date:5/16/2008).../ -- Veridex, LLC announced today that,its licensi... Holdings,(LabCorp), has commercially launched a n...new assay uses the biological specificity of ,DNA,...hylation of the gene,GST-Pi. Methylation is a modi...eridex is developing the methylation markers in th...
Breaking Medicine Technology:New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 2New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 3New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 4New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 5New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 6New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 7New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 8Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting 2Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7Engineers make first active matrix display using nanowires 4308 1Engineers make first active matrix display using nanowires 4308 2Engineers make first active matrix display using nanowires 4308 3Grubb 26 Ellis Healthcare REIT Acquires Cypress Station Medical Office Building in Houston 15602 1Grubb 26 Ellis Healthcare REIT Acquires Cypress Station Medical Office Building in Houston 15602 2Grubb 26 Ellis Healthcare REIT Acquires Cypress Station Medical Office Building in Houston 15602 3Human Pheromone Sciences Announces Quarterly and Full Year Results 4307 1Human Pheromone Sciences Announces Quarterly and Full Year Results 4307 2Human Pheromone Sciences Announces Quarterly and Full Year Results 4307 3Human Pheromone Sciences Announces Quarterly and Full Year Results 4307 4Federal Regulation Will Require Renovators to Work Safely with Lead Paint 15600 1Federal Regulation Will Require Renovators to Work Safely with Lead Paint 15600 2Federal Regulation Will Require Renovators to Work Safely with Lead Paint 15600 3
...s receiving both Tekturna and,Diovan reached targe...her agent alone, EAST HANOVER, N.J., March 26, 200...own patients taking two Novartis cardiovascular,me...a(R),(aliskiren) and the leading therapy Diovan(R)...blood pressure levels than those,using either agen...
...blem of Antibiotic Resistance,Published in Nature ...26, 2007 /PRNewswire/ --,Inimex Pharmaceuticals In...ystem trigger to cure infections without causing h...d in the April 2007,issue of Nature Biotechnology....and its,co-founders Dr. Bob Hancock and Dr. Brett ...
Other Medicine Technology:Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan 2Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan 3Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan 4Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan 5Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan 6Inimex Product Candidate is First Immune Defense Regulator to Cure,Infections Without Causing Harmful Inflammation 2
... Transport beds feature folding head end and foot ... With the head end and foot end deck panels folded...ximately 67". This compact length makes storage, d...is feature is not available on Model 4748B, Basic ...
.... Patient dignity. A single solution., ,Hill-Rom ...d to provide added safety where its needed. Its lo...the caregiver and patient from injury, while impro... other TotalCare® beds, but its different the...
...able Prefilled 28%-100% FIO 2 1000ML 0.45% Sodium... unmatched performance and ease of use. You can ob...le from 28% to 100% FIO 2 . We offer a wide select...P; 0.45% sodium chloride inhalation, USP; and 0.9%...
...led 750ML Sterile H 2 O W/O Adapter., ,Filled...er systems feature a dual-purpose reservoir with a...r secure attachment of a humidifier adapter. The o...ate from reaching oxygen delivery tubing. An audib...
Medicine Products: